At meeting held on 28 January 2015
Ajanta Pharma announced that the Board of Directors of the Company at its meeting held on 28 January 2015, inter alia, has approved sub-division of nominal value of equity shares of the Company from Rs. 5/- each to nominal value of Rs. 2/- each and consequential amendment to the Memorandum of Association and Articles of Association, subject to approval of Members of the Company to be taken by postal ballot.Powered by Capital Market - Live News
